Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Aspirin could be used as an anti-inflammatory drug, bringing relief to the thousands who suffer with shoulder pain, researchers at NDORMS have found.

Head of Department Professor Andrew Carr assesses a patient with shoulder pain
Head of Department Professor Andrew Carr assesses a patient with shoulder pain

In a study published in the journal Science Translational Medicine, our scientists looked at tendons taken from patients suffering from shoulder pain.

Dr Stephanie Dakin said: 'Shoulder pain is the third most common problem seen by orthopaedics specialists and with an aging population we will see more of this. There are various treatment options, from physiotherapy to drugs and injections and even surgery. Success rates can be variable. We wanted to understand the underlying processes that cause the problem.

Dr Dakin first developed her interest in the issue as a vet treating horses with tendon injuries, which can be life threatening in the animals. After completing a PhD researching inflammation in equine tendon disease, she has been funded by Arthritis Research UK to spend the last two years developing her findings and looking at how they can be applied to people as well.

She explained: 'The focus of this current work is to investigate inflammation in shoulder tendon injuries in groups of NHS patients at the Oxford University Hospitals. The purpose of this research is to improve understanding of the role of inflammation in tendon disease to find therapeutic targets – elements of the condition that can be targeted with drugs to relieve or cure it.'

The team found that the processes creating and sustaining inflammation were different in early and late stage tendon disease. They also found processes that appear to be responsible for recovery from tendon pain after treatment. A key finding was that aspirin, that staple of household medicine cabinets, could be an effective treatment.

Dr Dakin said: 'Looking at cells in the laboratory, we found that low dose aspirin has the potential to resolve tendon inflammation. We will now be conducting a clinical trial to investigate if low dose aspirin can help to prevent tendon injuries or treat patients with early stage tendon disease.'

You can read the full paper here.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.